GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICARES Medicus Inc (ROCO:6612) » Definitions » EV-to-Revenue

ICARES Medicus (ROCO:6612) EV-to-Revenue : 9.16 (As of Sep. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ICARES Medicus EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ICARES Medicus's enterprise value is NT$5,910.2 Mil. ICARES Medicus's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was NT$645.0 Mil. Therefore, ICARES Medicus's EV-to-Revenue for today is 9.16.

The historical rank and industry rank for ICARES Medicus's EV-to-Revenue or its related term are showing as below:

ROCO:6612' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.48   Med: 5.48   Max: 21.9
Current: 9.16

During the past 11 years, the highest EV-to-Revenue of ICARES Medicus was 21.90. The lowest was 3.48. And the median was 5.48.

ROCO:6612's EV-to-Revenue is ranked worse than
80.92% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: 3.15 vs ROCO:6612: 9.16

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-26), ICARES Medicus's stock price is NT$154.50. ICARES Medicus's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$15.29. Therefore, ICARES Medicus's PS Ratio for today is 10.10.


ICARES Medicus EV-to-Revenue Historical Data

The historical data trend for ICARES Medicus's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ICARES Medicus EV-to-Revenue Chart

ICARES Medicus Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.39 5.18 5.22 4.71 6.90

ICARES Medicus Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.39 7.59 6.90 5.82 9.67

Competitive Comparison of ICARES Medicus's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, ICARES Medicus's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ICARES Medicus's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where ICARES Medicus's EV-to-Revenue falls into.



ICARES Medicus EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

ICARES Medicus's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5910.205/644.998
=9.16

ICARES Medicus's current Enterprise Value is NT$5,910.2 Mil.
ICARES Medicus's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$645.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ICARES Medicus  (ROCO:6612) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

ICARES Medicus's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=154.50/15.29
=10.10

ICARES Medicus's share price for today is NT$154.50.
ICARES Medicus's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$15.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ICARES Medicus EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of ICARES Medicus's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ICARES Medicus Business Description

Traded in Other Exchanges
N/A
Address
Number 16, Sec.2, Sheng Yi Road, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices and designing, developing, manufacturing and sale of intraocular lenses and nanomedical devices. Its products include Artificial Lens. The Company manages segments based on geography, and divides segments into the R.O.C segment, the China segment, and the U.S.A segment. It earns the majority of its revenue from U.S.A. segment.

ICARES Medicus Headlines

No Headlines